SIM
ARRY

Sonora Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Sonora Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-34,065
Closed -$1.58M – 1871
2019
Q2 		$1.58M Sell
34,065
-4,079
-11% -$115K 0.18% 127
2019
Q1 		$930K Sell
38,144
-1,375
-3% -$28.6K 0.11% 142
2018
Q4 		$563K Sell
39,519
-7,150
-15% -$108K 0.08% 164
2018
Q3 		$709K Buy
46,669
+24,499
+111% +$375K 0.1% 148
2018
Q2 		$372K Sell
22,170
-24,805
-53% -$395K 0.06% 171
2018
Q1 		$767K Buy
46,975
+1,900
+4% +$30.4K 0.12% 126
2017
Q4 		$577K Buy
45,075
+40,300
+844% +$458K 0.09% 145
2017
Q3 		$58.7K Hold
4,775
– – 0.01% 316
2017
Q2 		$40K Hold
4,775
– – 0.01% 372
2017
Q1 		$42.7K Buy
+4,775
New +$50.8K 0.01% 358

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Sonora Investment Management's ARRY Position: Q3 2019 in Review

Sonora Investment Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 34,065 shares — an estimated $1.58M sold.

Sonora Investment Management first reported a position in ARRY in Q1 2017 and held it in 10 quarters. The position peaked at $1.58M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Sonora Investment Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Sonora Investment Management sold 34,065 Array Biopharma Inc shares in Q3 2019, an estimated $1.58M.
  • Sonora Investment Management first reported a position in Array Biopharma Inc in Q1 2017 and held it in 10 quarters.
  • Sonora Investment Management's Array Biopharma Inc position peaked at $1.58M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Sonora Investment Management's 13F filing for Q3 2019, filed 15 Oct 2019.